{
  "email_001.json": {
    "summary": "MRI volumetric analysis results for patient 203-012 in DNLI-456 Phase 2b study show Week 24 brain scan data ready for review with automated measurements and quality assurance report.",
    "quickActions": []
  },
  "email_002.json": {
    "summary": "Serious Adverse Event notification for patient 307-024 in study DNLI-789, requiring medical director review and guidance on whether hospitalization and treatment modifications are needed.",
    "quickActions": []
  },
  "email_003.json": {
    "summary": "Site 203 reports low investigational product inventory with only 2 vials remaining before patient 203-018's visit on December 2nd, but resupply shipment not arriving until December 5th, requesting expedited delivery or guidance on rescheduling.",
    "quickActions": []
  },
  "email_004.json": {
    "summary": "Three sites are significantly behind on data entry ahead of January 15, 2025 database lock: Site 105 (Mayo) with 3 visits, Site 209 (Hopkins) with 5 visits, and Site 312 (Cleveland) with 4 visits, requiring follow-up to ensure timely completion.",
    "quickActions": []
  },
  "email_005.json": {
    "summary": "Critical data quality issues at Site 307 including 23 unresolved queries (8 critical), missing source documentation for 5 patient visits, and 7 case report forms requiring corrections, with resolution needed by December 10, 2024 to avoid delaying database lock.",
    "quickActions": []
  }
}
